Venous occlusive disease: The latest in current management

Retina

Volumn 26, Issue 6 SUPPL., 2006, Pages

  Ai, Everett ^a,b   Yang, Sam S ^a,b  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; STEROID; TISSUE PLASMINOGEN ACTIVATOR; TRIAMCINOLONE; GLUCOCORTICOID;

CENTRAL RETINA VEIN OCCLUSION; CLINICAL TRIAL; CONFERENCE PAPER; EYE DISEASE; HUMAN; MEDICAL SOCIETY; RETINA VEIN OCCLUSION; SURGICAL TECHNIQUE; TREATMENT INDICATION; LASER COAGULATION; METHODOLOGY; REVIEW; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; GLUCOCORTICOIDS; HUMANS; LASER COAGULATION; PLATELET AGGREGATION INHIBITORS; RETINAL VEIN OCCLUSION; TREATMENT OUTCOME;

EID: 33747177601     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iae.0000236461.31264.c6     Document Type: Conference Paper

References (4)

1. Quinlan PM, Elman MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990;110:118.
2. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271.
3. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. Arch Ophthalmol 1986;104:34.
4. Hayreh SS, Rojas P, Podhajsky P, et al. Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 1983;90:488.